Northwest Biotherapeutics reported 11.67 in PE Price to Earnings for its fiscal quarter ending in September of 2022.





Pe Change Date
AstraZeneca 29.59 2.3 Mar/2026
Bristol-Myers Squibb 9.08 0.2 Mar/2026
Eisai 35.61 8.98 Mar/2026
Merck 16.52 2.6 Mar/2026
Northwest Biotherapeutics 11.67 6.93 Sep/2022
Pfizer 9.32 5.16 Mar/2026
Roche Holding 16.09 3.51 Dec/2025